Twitter | Search | |
AstraZeneca
We're a global, science-led biopharmaceutical company & our innovative medicines are used by millions of patients worldwide. We believe in what science can do.
4,999
Tweets
1,130
Following
139,387
Followers
Tweets
AstraZeneca 8h
Hear a broader European perspective on secondary prevention of in our interview with Gunnar Brandrup-Wognsen. His background and current role provide a unique perspective.
Reply Retweet Like
AstraZeneca 23h
For patients with locally advanced (Stage III) , the current standard of care after chemoradiation therapy is active surveillance.
Reply Retweet Like
AstraZeneca Feb 21
is an approach to combating that aims to help the immune system fight tumour cells
Reply Retweet Like
AstraZeneca Feb 20
is responsible for nearly 1 in 5 deaths around the world. We are continuing to push the boundaries of to address this unmet need
Reply Retweet Like
AstraZeneca Feb 20
Read our LabTalk blog featuring a roundtable debate on secondary prevention of recurrent atherothrombotic events among high-risk patients. Find out what the experts said:
Reply Retweet Like
AstraZeneca Feb 20
We strive to deliver meaningful science to improve the lives of patients through innovative research. We’re working to bring new hope to patients living with .
Reply Retweet Like
AstraZeneca Feb 19
We are excited to see what the future holds. By following the science, the opportunities are endless.
Reply Retweet Like
AstraZeneca Feb 19
Mark Mallon talks about how we focus on scientific leadership: It all starts with science – you need to trust the scientists and, if the medicines are good, they’ll generate the value.
Reply Retweet Like
AstraZeneca Feb 19
We aim to improve the lives of patients by exploring the potential of . Harnessing the power of IO is one way we hope to achieve our vision of eliminating as a cause of death.
Reply Retweet Like
AstraZeneca retweeted
One Person Closer Feb 18
As a , you can help your patients understand if a may be suitable for them. Start the discussion.
Reply Retweet Like
AstraZeneca Feb 18
Our in is about pushing the boundaries of science to address unmet needs for patients
Reply Retweet Like
AstraZeneca Feb 17
can be diagnosed at multiple stages, but there have been limited scientific advances for locally advanced (Stage III) patients for over a decade. We are focused on serving this unmet need through research.
Reply Retweet Like
AstraZeneca Feb 17
We think it’s time for a shift in the approach to earlier stages of .
Reply Retweet Like
AstraZeneca retweeted
Jonathan Dry Feb 15
Reply Retweet Like
AstraZeneca retweeted
Cogent Ambassadors Feb 15
really enjoyed working with Kate today. She's a great role model to encourage women into engineering.
Reply Retweet Like
AstraZeneca retweeted
MEDS Feb 15
A team from currently conducting a training on the Healthy Heart Africa (HHA) project to staff in relation to prevention and treatment of Hypertension.
Reply Retweet Like
AstraZeneca retweeted
MedImmune Feb 14
Reply Retweet Like
AstraZeneca Feb 13
Our 5R framework encourages project teams to come together, and work together, which leads to improved R&D productivity.
Reply Retweet Like
AstraZeneca Feb 12
According to Dean Brown, focusing on the “Right Target” plays a significant role in increasing our R&D productivity.
Reply Retweet Like
AstraZeneca Feb 12
Congratulations on your centenary! We look forward to being neighbours on the CBC
Reply Retweet Like